Reading view

There are new articles available, click to refresh the page.

RFK Jr. insists upcoming ‘Make America Healthy Again’ report won’t target farming

Secretary of Health and Human Services Robert F. Kennedy Jr. testifies before a Senate Appropriations subcommittee on Tuesday, May 20, 2025. (Screenshot from committee webcast)

Secretary of Health and Human Services Robert F. Kennedy Jr. testifies before a Senate Appropriations subcommittee on Tuesday, May 20, 2025. (Screenshot from committee webcast)

WASHINGTON — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. testified before Congress on Tuesday that a major report due out later this week from his agency will not disparage farmers or a commonly used pesticide.

Kennedy, who has long been critical of certain aspects of modern agriculture and processed food, at a U.S. Senate hearing urged lawmakers to read the widely anticipated “Make America Healthy Again” report once it’s published Thursday, but didn’t go into details about any possible recommendations.

“Everybody will see the report,” Kennedy said. “And there’s nobody that has a greater commitment to the American farmer than we do. The MAHA movement collapses if we can’t partner with the American farmer in producing a safe, robust and abundant food supply.”

His comments followed stern questioning from Mississippi Republican Sen. Cindy Hyde-Smith, who said she had read news reports from “reliable sources” that the MAHA Commission’s initial assessment “may unfairly target American agriculture, modern farming practices and the crop protection tools that roughly 2% of our population relies on to help feed the remaining 98%.”

“If Americans lose confidence in the safety and integrity of our food supply due to the unfounded claims that mislead consumers, public health will be at risk,” Hyde-Smith said. “I’ve said this before, and it’s worth saying again, countries have gone to war over many things — politics, religion, race, trade, natural resources, oil, pride, you name it — but threaten a nation’s food supply and allow people to go hungry. Let’s see what happens then.”

Hyde-Smith, who was her home state’s commissioner of agriculture and commerce from 2012 to 2018, probed Kennedy about his past work in environmental law and whether he might be inserting “confirmation bias” into the forthcoming report.

She asked Kennedy if he would try to change the current approval for glyphosate, a commonly used herbicide, that she referred to as “one of the most thoroughly studied products of its kind.”

“We’re talking about more than 1,500 studies and 50-plus years of review by the EPA and other leading global health authorities that have affirmed its safety when used as directed,” Hyde-Smith said. “Have you been able to review thousands of studies and decades of scientific review in a matter of months?”

Kennedy responded that her “information about the report is just simply wrong.”

“The drafts that I’ve seen, there is not a single word in them that should worry the American farmer,” Kennedy said.

Hyde-Smith continued her questioning and told Kennedy that it would be “a shame if the MAHA commission issues reports suggesting, without substantial facts and evidence, that our government got things terribly wrong when it reviewed a number of crop protection tools and deemed them to be safe.”

Home energy program in Maine

Several other Republicans on the Senate Appropriations Labor-HHS-Education Subcommittee raised concerns during the two-hour hearing about how Kennedy has run HHS since they confirmed him in February.

Maine Sen. Susan Collins, chairwoman of the full Appropriations Committee, brought up the Low Income Home Energy Assistance Program, or LIHEAP, which the Trump administration has called on Congress to eliminate.

“The LIHEAP program, which we’ve talked about, is absolutely vital for thousands of older Mainers and low-income families,” Collins said. “It helps them avoid the constant worry of having to choose between keeping warm, buying essential foods and medications and other basic necessities.”

Kennedy sought to distance himself from the president’s budget request, saying that he understands “the critical, historical importance of this program.”

“President (Donald) Trump’s rationale and (the Office of Management and Budget’s) rationale is that President Trump’s energy policies are going to lower the cost of energy … so that everybody will get lower cost heating oil,” Kennedy said.

NIH indirect costs

Subcommittee Chairwoman Shelley Moore Capito, R-W.Va., brought up several issues with Kennedy, including efforts to change how much the National Institutes of Health provides to medical schools and research universities for Facilities and Administrative fees, often called indirect costs.

NIH sought to set that amount at 15% across the board for any institution that receives a research grant from the agency, a significantly lower amount than many of the organizations had negotiated over the years, bringing about strong objections from institutions of higher education.

That NIH policy has not taken effect as several lawsuits work their way through the federal court system.

Kennedy indicated NIH has figured out a way to help medical schools and research universities pay for items like gloves, test tubes and mass spectrometers, particularly at state schools.

“In the public universities, we are very much aware that those universities are using the money well, that it is absolutely necessary for them. And we’re looking at a series of different ways that we can fund those costs through them,” Kennedy said. “But not through the independent, indirect cost structure, which loses all control, which deprives us of all control of how that money is spent.”

Kansas Sen. Jerry Moran, a Republican, brought up the measles outbreak and pressed Kennedy on whether HHS needed additional resources to help his home state and others get the virus under control.

Kennedy testified the “best way to prevent the spread of measles is through vaccination” and that HHS has been urging “people to get their MMR vaccines.”

South Dakota grant on mine safety

South Dakota Sen. Mike Rounds called on Kennedy to continue fixing issues created earlier this year when HHS fired people working on mine safety issues at the National Institute for Occupational Safety and Health.

“My office has learned that staff at NIOSH’s Spokane mining research division have been laid off. This office focuses on the unique challenges of Western mining operations that are often more geologically complex and exposed to harsher conditions,” Rounds said. “This division provides critical technical support for institutions like the South Dakota School of Mines and Technology, which recently received a $1.25 million grant to improve underground mining safety. However, the grant has now been canceled due to loss of oversight from the Spokane office.

“This is not just a missed opportunity, it undermines our ability to meet national security goals tied to mineral independence and supply chain resilience.”

Kennedy testified that he’s been able to bring back 238 workers at the agency and said he would work with Rounds to address ongoing issues.

Pledge to fund Head Start, but no dollar amount

Alabama Sen. Katie Britt, a Republican, asked Kennedy about news reports earlier this year that HHS would ask Congress to zero out funding for Head Start, one of numerous programs left out of the administration’s skinny budget request. Head Start provides early learning, health, family and development programs for free for children from low-income families.

Kennedy testified that eliminating Head Start would likely not be in the full budget request, which is set to be released later this year, though the White House budget office has not said when. He said it would ask Congress to fully fund the program, but didn’t share a dollar amount.

“There’s 800,000 of the poorest kids in this country who are served by this program. It not only teaches the kids preschool skills — reading, writing and arithmetic — before they get to prepare them for school. But it also teaches the parents and teaches them how to be good parents.”

Kennedy said there are challenges faced by the Head Start program that he hopes to change during the next four years, including the quality of the food.

“The food they’re serving at Head Start is terrible. You need to change that,” Kennedy said. “We’re poisoning the poorest kids from their youngest years, and we’re going to change that.”

Trump signs order aiming to lower U.S. drug costs to match prices abroad

A pharmacy manager retrieves a bottle of antibiotics. (Photo by Joe Raedle/Getty Images)

A pharmacy manager retrieves a bottle of antibiotics. (Photo by Joe Raedle/Getty Images)

WASHINGTON — President Donald Trump signed an executive order Monday aimed at lowering drug prices by pressuring pharmaceutical companies to align their U.S. pricing models with those in similarly wealthy countries.

“We’ll slash the cost of prescription drugs and will bring fairness to America,” Trump said at a morning White House event. “We’re all gonna pay the same.”

The executive order, which the White House dubbed the “most-favored-nation” policy, gives pharmaceutical companies 30 days to negotiate lower drug prices with the government.

If no deal is reached in that time, Trump said a new rule will be set so that the United States will have a price model similar to the lower rates patients abroad pay. According to the executive order, Health and Human Services Secretary Robert F. Kennedy Jr. would be responsible for the rulemaking  “to impose most-favored-nation pricing.”

“We are going to pay the lowest price there is in the world,” Trump said.

Prescription pricing for brand-name drugs in the U.S. is more than four times higher than in similar countries, according to a 2024 study by the nonpartisan research nonprofit RAND.

Clear price targets

A White House official previewing the policy in a background call with reporters Monday said the president will direct the Department of Commerce to “take all appropriate action” on countries that “suppress drug pricing abroad.”

The Food and Drug Administration will also consider expanding imports of pharmaceutical drugs from nations beyond Canada, the White House official said.

Former President Joe Biden issued an executive order to direct the FDA to work with states to import prescription drugs from Canada.

The White House official said Kennedy “will set clear targets for price reductions across all markets in the United States.”

Kennedy appeared at the White House alongside the president Monday morning.

“The United States will no longer subsidize the health care of foreign countries, which is what we were doing,” Kennedy said. “If the Europeans raise their price of their drugs by just 20%, that is tens of trillions that can be spent on innovation and the health of all people all across the globe.”

Trump said Monday the drug pricing policy would be included in the “one, big, beautiful,” reconciliation bill that is the top priority of congressional Republicans. The measure is also expected to provide tax cuts and a significant funding increase to border security.

Staff on the House Energy and Commerce Committee told reporters twice during a background briefing around the same time that most favored nation prescription drug pricing would not be in that reconciliation package.

First term

The order is similar to an effort the president made in his first term, which was struck down in federal court.

The White House official said Monday’s order is an expansion of those first-term efforts, which tried to apply the pricing model for those with Medicare – the health insurance program for those who are 65 or older and certain people under 65 who have disabilities – to 50 drugs.

“The expectation should not be that we will just be pursuing that same rulemaking,” a White House official said. “We have moved on from that for broader action.”

The pharmaceutical industry has long opposed such a move and is already bracing for the president’s planned tariffs on prescription drugs. 

More details on specific actions in Medicare will be announced later, according to a White House official.

“We will be taking action in the Medicare program if the pharmaceutical companies do not come to the table and lower their prices across markets,” the White House official said.

Effort unserious, leading Democrat says

U.S. Senate Finance Committee ranking member Ron Wyden, Democrat of Oregon, slammed Monday’s executive order.

“If Trump was serious about lowering drug prices, he would work with Congress to strengthen Medicare drug price negotiations, not just sign a piece of paper,” Wyden said.

The Inflation Reduction Act that Democrats passed along party lines in 2022 when they held unified control of Washington allowed for drug negotiating pricing that aims to lower drug costs for those with Medicare.

“Democrats took on Big Pharma and won by finally giving Medicare the power to negotiate lower drug prices on behalf of seniors and capping their out-of-pocket costs for expensive prescriptions,” Wyden said, referring to the law.

Jennifer Shutt contributed to this report.

Nonpartisan poll finds ‘remarkably low’ trust in federal health agencies

Robert F. Kennedy Jr., the secretary of Health and Human Services, testifies during his Senate Finance Committee confirmation hearing at the Dirksen Senate Office Building on Jan. 29, 2025, in Washington, D.C. (Photo by Win McNamee/Getty Images)

Robert F. Kennedy Jr., the secretary of Health and Human Services, testifies during his Senate Finance Committee confirmation hearing at the Dirksen Senate Office Building on Jan. 29, 2025, in Washington, D.C. (Photo by Win McNamee/Getty Images)

WASHINGTON — Less than half of Americans have confidence in federal public health agencies’ ability to regulate prescriptions, approve vaccines and respond to outbreaks, according to a poll released Tuesday by the nonpartisan health research organization KFF.

The survey shows that just 46% of the people questioned have at least some confidence in federal agencies ensuring the safety and effectiveness of prescription drugs.

Even fewer, 45%, have confidence in the safety and effectiveness of vaccines and only 42% said they have confidence federal health agencies to respond to infectious disease outbreaks, like bird flu and measles.

An especially low percentage of those polled, 32%, had either some confidence or a lot of confidence in federal health agencies acting independently without interference from outside interests.

“There are remarkably low levels of trust in the nation’s scientific agencies, shaped by partisan perspectives, and that presents a real danger for the country if and when another pandemic hits,” KFF President and CEO Drew Altman wrote in a statement accompanying the poll.

Confidence in agencies sags or rises by party affiliation

The percentage of people overall who hold confidence in the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention to provide reliable information about vaccines has dropped since a similar survey in September 2023, though party affiliation shows differing trends.

Democrats with a fair amount or great deal of trust in the FDA’s vaccine information has decreased from 86% to 67%, while trust among Republicans has increased from 42% to 52%.

When combined with independents, overall trust in the FDA’s information about vaccines has decreased, from 61% to 57%.

Confidence in the CDC providing reliable information about vaccines has also shifted based on party affiliation.

During the Biden administration, 88% of Democrats had a fair amount or great deal of trust in the CDC, though that has since dropped to 70%. Republicans have started to come back around to the CDC’s vaccine information, with their level of trust increasing from 40% to 51%.

Altogether, trust in CDC has dropped from 63% to 59%, according to the survey.

“The overall level of trust in each case is similar to where it stood in September 2023, though the poll reveals significant partisan shifts as the second Trump administration and Health and Human Services Secretary Robert F. Kennedy Jr. have started to change vaccine policies and messaging,” the poll states.

Local sources trusted

Health care providers and local public health departments are overwhelmingly looked to as trusted sources for reliable information on vaccines, according to the survey.

Eighty-two percent of respondents said they either have a great deal or a fair amount of trust in doctors and health care providers to give them reliable information about vaccines.

Eighty-one percent said they trust their child’s pediatrician, 66% responded they have confidence in their local public health department, 59% believe in the CDC, 57% trust the FDA and 51% have confidence in pharmaceutical companies to provide factual information about vaccines.

Those polled held less trust in politicians, with 41% believing Kennedy’s comments about vaccines and 37% trusting President Donald Trump “to provide reliable information about vaccines,” according to the poll.

A majority of those surveyed, however, are somewhat or very confident in the safety of several vaccines, including 83% for measles, mumps and rubella, or the MMR vaccine; 82% for pneumonia; 79% for shingles; 74% for the flu; and 56% for COVID-19.

The poll included 1,380 U.S. adults contacted online or via telephone from April 8-15, for a margin of error of plus or minus 3 percentage points. 

❌